April 1, 2022 – The risk of suffering an ischemic stroke, the most common type of cerebrovascular event, is 16% less in people who have green spaces less than 300 meters from their homes. This has been revealed in a joint study by the Hospital del Mar Medical Research Institute, Hospital del Mar, the Catalan Health Quality and Assessment Agency (AQuAS) from the Catalan Government's Department of Health and the Barcelona Institute for Global Health (ISGlobal), a centre promoted by the "la Caixa" Foundation.

April 1, 2022 —  Royal Philips, a global leader in health technology, announced new additions to its innovative integrated portfolio of cardiology solutions at the American College of Cardiology’s Annual Scientific Session & Expo (

April 1, 2022 — Cardiologs announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in Washington, DC, from April 2-4, 2022. 

March 31, 2022 – Healthcare AI solutions provider Aidoc will be delivering a live demonstration of its comprehensive AI for cardiovascular care coordination suite at ACC 2022, April 2-4, at the Walter E. Washington DC, at booth #FH14. Aidoc experts will be available to share their perspective on true AI, alongside the immediate and long-term value of a comprehensive AI platform as opposed to siloed, point solutions for cardiovascular pathologies.

March 31, 2022 – Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research data and lead discussions on medica

March 31, 2022 – CathWorks has announced that the results of its most recent outcomes study on the CathWorks FFRangio system will be presented by Dr. Guy Witberg from Rabin Medical Center, Petah Tikva, Israel on Sunday, April 3 at the annual American College of Cardiology (ACC) conference in Washington, DC.

March 31, 2022 — In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset of its

MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March. This data was drawn from dicardiology.com’s 163,000 viewers over the course of the month.

1. FDA Recalls Quinapril Hydrochloride and Hydrochlorothiazide Tablets by Pfizer

2. David Bennett, Pig Heart Transplant Patient, Dies

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.

March 31, 2022 – Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it easier to predict if a person will have a heart attack.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now